Jasper Therapeutics, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
JSPR, JSPRW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2200 Bridge Pkwy Suite #102, Redwood City, CA

Insiders trading volume in the past year

Jasper Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Abingworth LLP 10%+ Owner $119M Mar 21, 2022
Velan Capital Investment Management LP 10%+ Owner $18.6M Feb 8, 2024
Carlyle Group Inc. Former 10% Owner $13.8M Feb 8, 2024
Qiming U.S. Healthcare Fund II, L.P. 10%+ Owner $5.53M Jan 27, 2023
Roche Holding Ltd 10%+ Owner $2.95M Jan 25, 2023
Howard I. Hoffen Former Director $1.49M Sep 24, 2021
Kenneth F. Clifford Former Officer $1.49M Sep 24, 2021
Amplitude Healthcare Holdings LLC 10%+ Owner $1.49M Sep 24, 2021
Balaji Venkataraman Former Director And Officer $1.49M Sep 24, 2021
Jeetinder Singh Mahal Chief Operating Officer $1.16M -$19.9K -1.69% Jun 4, 2025
Judith Anne Shizuru Director $381K +$99.6K +35.4% Sep 22, 2025
Ron Martell President and CEO, Director $180K +$99.6K +124% Sep 22, 2025
Thomas G. Wiggans Director $114K +$99.6K +702% Sep 22, 2025
Svetlana Lucas Director $48.6K +$48.6K Sep 22, 2025
William Lis Director $34.7K Oct 13, 2023
Lawrence Otto Klein Director $15.9K Jun 7, 2023
Edwin Jonathan Tucker Chief Medical Officer $1.67K Jun 4, 2025
Herb Cross Chief Financial Officer Jun 4, 2025
Chris Nolet Director Jul 3, 2025
Vishal Kapoor Director Jul 3, 2025
Kurt Von Emster Director Jul 3, 2025
Scott C. Brun Director Jul 3, 2025
Kevin N. Heller Executive Vice President, Research and Development Mar 21, 2022
Anna Louise French Director Jun 6, 2024

Recent Insider Transactions by Companies or Individuals for Jasper Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.